GPs 'as good as consultants' at referring for cancer tests

GPs are as good as consultants at referring for cancer tests and direct access to scans can more than halve waits for patients, researchers have found.

Direct access testing - allowing GPs to refer patients for diagnostic testing without first referring to or consulting with a specialist - performs ‘as well as, and on some measures better than, consultant triaged testing on measures of disease detection, appropriateness of referrals, interval from referral to testing and patient and GP satisfaction’, a systematic review of 60 studies has concluded.

Earlier this year, a GPonline poll revealed that nearly half of GPs have had a referral on the two-week cancer pathway bounced back or downgraded to non-urgent - often for patients later found to have cancer. It was also found that GPs were being denied direct access to testing despite repeated warnings from charities and NHS officials over the importance of rapid diagnosis.

Research by a team from Oxford University, published in the British Journal of General Practice (BJGP), dismissed claims that direct GP access to tests can increase numbers of unnecessary tests.

Direct access

Although the authors found ‘no significant difference’ in the proportion of patients diagnosed via GP direct access referrals and the proportion of patients who were diagnosed following a consultation with a specialist, the waiting time for testing was found to be significantly shorter in patients seen by GPs with direct access to testing (mean 31.9 days), compared with those who had to be referred to a specialist (mean 76.6 days).

However, despite this reduction in patients’ time to testing there appeared to be no corresponding reduction in time to diagnosis, the researchers found.

GPs and patients reported high satisfaction with direct access testing, with the majority of patients saying that they felt seeing a specialist prior to testing was ‘not necessary’. Although 80.9% of referrals for cancer scans by consultants were found to be appropriate compared with 66.4% by GPs, the researchers said the difference was 'not significant'.

The authors said: 'This review has re-emphasised the importance of a whole-pathway redesign, and the need to focus efforts to reduce diagnostic delay on all intervals between symptomatic presentation to GP and final diagnosis.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP workload fears over antibody testing rollout for 'no clinical benefit'

GP practices are being contacted by patients asking for antibody tests as the government...

Top GP spells out actions to protect BAME staff after PHE review fails to offer solutions

Top GP spells out actions to protect BAME staff after PHE review fails to offer solutions

The BMA's top GP has spelled out the advice and support practices need to protect...

GP time per patient slumps to lowest level in half a decade

GP time per patient slumps to lowest level in half a decade

GP time available per patient has dropped by six and a half minutes since 2015 -...

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

An uncompromising defender of the NHS: colleagues remember Dr Ron Singer

Colleagues and friends have paid tribute after the death of East London GP Dr Ron...

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

COVID-19 death rate highest among BAME groups, delayed PHE review confirms

Death rates from COVID-19 are highest among patients from BAME groups, according...

GPs face hundreds of complaints over shielding and PPE during pandemic

GPs face hundreds of complaints over shielding and PPE during pandemic

GP practices have faced hundreds of complaints over issues including shielding and...